Skip to content

Contact Us
Join Us
Linkedin

Our Company
Our Commitment
Our Innovation
Investors and Media
- Column
- Column

Our Company
Our Commitment
Our Innovation
Investors and Media
- Column
- Column

Contact Us
Join Us
Linkedin

Cookie Policy

Cookie Policy

Our Company
About Us
Governance
Our Culture
Contact Us
Join Us
LinkedIn

Our Commitment
Diabetic Macular Edema I OCS-01
Post Ocular Surgery I OCS-01
Dry Eye Disease I OCS-02
Uveitis ׀ OCS-02
Acute Optic Neuritis I OCS-05

Our Innovation
Pipeline
Clinical Trials
Science
Publications

Investors and Media
Overview
Stock Information
News Releases
Events & Presentations
Corporate Governance
SEC Filings
Public Disclosures
Investor FAQs
Investor Resources

© 2024 Oculis All Rights Reserved

Terms of Use
Privacy Notices
Cookie Policy
Expanded Access Policy